Use of dapsone as a neuroprotector in cerebral infarction
The invention relates to the use of dapsone as the first effective treatment against the disabling consequences associated with cerebral infarction in patients. Dapsone was evaluated as a neuroprotector in the cerebral infarction model produced by the occlusion of the middle cerebral artery in rats...
Saved in:
| Main Author | |
|---|---|
| Format | Patent |
| Language | English |
| Published |
25.10.2006
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The invention relates to the use of dapsone as the first effective treatment against the disabling consequences associated with cerebral infarction in patients. Dapsone was evaluated as a neuroprotector in the cerebral infarction model produced by the occlusion of the middle cerebral artery in rats and in patients suffering from acute cerebral infarction caused by thromboembolism. In both studies, dapsone displayed a reduction of between 70 and 90 % in the adverse effects which occur as a consequence of the infarction. |
|---|---|
| AbstractList | The invention relates to the use of dapsone as the first effective treatment against the disabling consequences associated with cerebral infarction in patients. Dapsone was evaluated as a neuroprotector in the cerebral infarction model produced by the occlusion of the middle cerebral artery in rats and in patients suffering from acute cerebral infarction caused by thromboembolism. In both studies, dapsone displayed a reduction of between 70 and 90 % in the adverse effects which occur as a consequence of the infarction. |
| Author | RIOS CASTANEDA LUIS C. PERIFER,ALTAGRACIA MARTINEZ M. CAL DEL,NADER KAWACHI J. PUENTE DE PIED,KRAVZOV JINICH J |
| Author_xml | – fullname: RIOS CASTANEDA LUIS C. PERIFER,ALTAGRACIA MARTINEZ M. CAL DEL,NADER KAWACHI J. PUENTE DE PIED,KRAVZOV JINICH J |
| BookMark | eNrjYmDJy89L5WSwDC1OVchPU0hJLCgGCigkFiskKuSllhblFxTll6Qml-QXKWTmKSSnFqUmFSXmANlpiUXJJZn5eTwMrGmJOcWpvFCam0HezTXE2UM3tSA_PrW4IDE5NS-1JN7Zz9DC1MjcxNLRmLAKAHRTL5I |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | CN1852749A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN1852749A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:16:50 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN1852749A3 |
| Notes | Application Number: CN200480026445 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061025&DB=EPODOC&CC=CN&NR=1852749A |
| ParticipantIDs | epo_espacenet_CN1852749A |
| PublicationCentury | 2000 |
| PublicationDate | 20061025 |
| PublicationDateYYYYMMDD | 2006-10-25 |
| PublicationDate_xml | – month: 10 year: 2006 text: 20061025 day: 25 |
| PublicationDecade | 2000 |
| PublicationYear | 2006 |
| RelatedCompanies | UNIV AUTONOMA METROPOLITANA |
| RelatedCompanies_xml | – name: UNIV AUTONOMA METROPOLITANA |
| Score | 2.648446 |
| Snippet | The invention relates to the use of dapsone as the first effective treatment against the disabling consequences associated with cerebral infarction in... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Use of dapsone as a neuroprotector in cerebral infarction |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061025&DB=EPODOC&locale=&CC=CN&NR=1852749A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS8MwED_mFPVNpzK_8yB9K9Y2WdeHIi5tGcK6IZvsbTRtwgbSjrbiv28S2unL3o4EjkvI3SW5u98BPAlhWanlcJMQV5iY2QOTicwzhwxnqkdg5ur2bZN4MF7g9yVZdmDd1sJonNAfDY4oNSqV-l5re739-8QKdG5l9cw2cqh4jeZ-YOxex9JfEiMY-eFsGkypQalPYyP-8FWNsIu9twM4VJdohbIffo5UTcr2v0OJzuBoJnnl9Tl0eN6DE9r2XevB8aQJd0uy0bzqArxFxVEhUJao9A2OkgolSINRNkgLRYk2OUp5qSLBX5IW8girhVzCYxTO6diUMqx2y13RuBXWuYJuLnn2AWE3S7LE5jZPPYz5C-OuwCRlYsiJm9jONfT3cbnZP3ULp_pLQdpim9xBty6_-b10sjV70PvzCx9Ygpk |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf9MHsbRG3lrKHxUgHmQqDGDC8kXVrA4kZhM3479s2A33h7dIml2vTu2t7d78DeJCy1UparrAJodLG3GnbXKae3eE41T0CU2ratw2jdjjFbzMyq8BiWwtjcEJ_DDii0qhE6Xth7PX67xMrMLmV-SNfqqHVc3_iB9budaz8JbGCrt8bj4IRsxjzWWRFH76uEabYezmAQ6qxefXF6bOra1LW_x1K_xSOxopXVpxBRWR1qLFt37U6HA_LcLciS83Lz8Gb5gKtJEpjnb4hUJyjGBkwyhJpYbVBywwlYqMjwV-KluoI64VcQLPfm7DQVjLMd8uds2grrHsJ1UzxbADCNI3T2BGOSDyMxRMXVGKScNkRhMaOewWNfVyu9081oRZOhoP54DV6v4ET872g7LJDbqFabL7FnXK4Bb83e_ULY1OFhg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+dapsone+as+a+neuroprotector+in+cerebral+infarction&rft.inventor=RIOS+CASTANEDA+LUIS+C.+PERIFER%2CALTAGRACIA+MARTINEZ+M.+CAL+DEL%2CNADER+KAWACHI+J.+PUENTE+DE+PIED%2CKRAVZOV+JINICH+J&rft.date=2006-10-25&rft.externalDBID=A&rft.externalDocID=CN1852749A |